144//SEC Filing
Werewolf Therapeutics, Inc. 144
Accession 0001628280-25-055072
CIK 0001691428other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:39 PM ET
Size
298.8 KB
Accession
0001628280-25-055072
Documents
Issuer
UBS Oncology Impact Fund L.P.
CIK 0001691428
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001691428
Filing Metadata
- Form type
- 144
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 4:39 PM ET
- Size
- 298.8 KB